1. Home
  2. BRNS vs HHS Comparison

BRNS vs HHS Comparison

Compare BRNS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • HHS
  • Stock Information
  • Founded
  • BRNS 2016
  • HHS 1923
  • Country
  • BRNS United Kingdom
  • HHS United States
  • Employees
  • BRNS N/A
  • HHS N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • HHS Advertising
  • Sector
  • BRNS Health Care
  • HHS Consumer Discretionary
  • Exchange
  • BRNS Nasdaq
  • HHS Nasdaq
  • Market Cap
  • BRNS 40.0M
  • HHS 30.3M
  • IPO Year
  • BRNS 2021
  • HHS N/A
  • Fundamental
  • Price
  • BRNS $0.90
  • HHS $4.00
  • Analyst Decision
  • BRNS Strong Buy
  • HHS
  • Analyst Count
  • BRNS 1
  • HHS 0
  • Target Price
  • BRNS $3.00
  • HHS N/A
  • AVG Volume (30 Days)
  • BRNS 10.9K
  • HHS 30.4K
  • Earning Date
  • BRNS 08-07-2025
  • HHS 08-07-2025
  • Dividend Yield
  • BRNS N/A
  • HHS N/A
  • EPS Growth
  • BRNS N/A
  • HHS N/A
  • EPS
  • BRNS N/A
  • HHS N/A
  • Revenue
  • BRNS $14,969,000.00
  • HHS $181,355,000.00
  • Revenue This Year
  • BRNS N/A
  • HHS $6.54
  • Revenue Next Year
  • BRNS N/A
  • HHS N/A
  • P/E Ratio
  • BRNS N/A
  • HHS N/A
  • Revenue Growth
  • BRNS 4381.74
  • HHS N/A
  • 52 Week Low
  • BRNS $0.64
  • HHS $3.24
  • 52 Week High
  • BRNS $1.58
  • HHS $8.87
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 48.03
  • HHS 44.31
  • Support Level
  • BRNS $0.83
  • HHS $3.24
  • Resistance Level
  • BRNS $0.94
  • HHS $4.14
  • Average True Range (ATR)
  • BRNS 0.05
  • HHS 0.46
  • MACD
  • BRNS -0.00
  • HHS -0.00
  • Stochastic Oscillator
  • BRNS 34.88
  • HHS 34.42

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: